ArrowArtboardCreated with Sketch.Title ChevronTitle ChevronIcon FacebookIcon LinkedinIcon Mail ContactPath LayerIcon MailPositive ArrowIcon PrintIcon Twitter
Pharmaceuticals

2 Indian drugmakers seek approval for COVID-19 vaccines

Move follows Pfizer application, with first licensing possible in a few weeks

Passengers wait in line to have their temperature checked at a railway station in Mumbai on Nov. 26.   © Reuters

NEW DELHI -- Two Indian companies have applied for emergency approval of their COVID-19 vaccine candidates in a country that is the second-worst hit by the coronavirus pandemic, days after U.S. drugmaker Pfizer did the same.

Sponsored Content

About Sponsored Content This content was commissioned by Nikkei's Global Business Bureau.

Nikkei Asian Review, now known as Nikkei Asia, will be the voice of the Asian Century.

Celebrate our next chapter
Free access for everyone - Sep. 30

Find out more